LAVA Therapeutics BV (LVTX) Social Stream
LAVA THERAPEUTICS NV (LVTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering LAVA THERAPEUTICS NV.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 3 | $24 | $22 | $23 | $1.82 | 1163.74% |
| 2021-11-16 | 3 | $23 | $20 | $21.666 | $1.82 | 1090.44% |
| 2022-03-24 | 3 | $23 | $20 | $21 | $1.82 | 1053.85% |
| 2022-04-20 | 2 | $23 | $19 | $20.666 | $1.82 | 1035.49% |
| 2022-05-17 | 3 | $23 | $19 | $20.666 | $1.82 | 1035.49% |
| 2022-05-18 | 3 | $25 | $19 | $22.333 | $1.82 | 1127.09% |
| 2022-06-01 | 3 | $25 | $18 | $22 | $1.82 | 1108.79% |
| 2022-08-02 | 3 | $25 | $18.001 | $22 | $1.82 | 1108.79% |
| 2022-09-16 | 4 | $25 | $6 | $18 | $1.82 | 889.01% |
| 2022-09-27 | 5 | $28 | $6 | $18.75 | $1.82 | 930.22% |
| 2022-10-25 | 5 | $28 | $6 | $16.8 | $1.82 | 823.08% |
| 2022-11-17 | 5 | $28 | $6 | $17.2 | $1.82 | 845.05% |
| 2022-12-01 | 4 | $27 | $6 | $17 | $1.82 | 834.07% |
| 2023-04-13 | 5 | $27 | $6 | $17 | $1.82 | 834.07% |
| 2023-04-14 | 5 | $27 | $6 | $15.2 | $1.82 | 735.16% |
| 2023-06-12 | 5 | $28 | $6 | $13.8 | $1.82 | 658.24% |
| 2023-06-15 | 5 | $18 | $6 | $9.8 | $1.82 | 438.46% |
| 2023-08-22 | 4 | $10 | $6 | $7.75 | $1.82 | 325.82% |
| 2023-08-23 | 4 | $10 | $6 | $7.333 | $1.82 | 302.91% |
| 2023-11-17 | 4 | $11 | $6 | $7.666 | $1.82 | 321.21% |
The Trend in the Analyst Price Target
Over the past 18 months, LVTX's average price target has gone down $13.
Over the past 31 weeks, LVTX's average upside potential has been 500.87%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-12 | 5 | 27 | 6 | 17.00 | 1.55 | 996.77% |
| 2023-04-13 | 5 | 27 | 6 | 17.00 | 1.60 | 962.5% |
| 2023-04-14 | 5 | 27 | 6 | 15.20 | 1.78 | 753.93% |
| 2023-05-25 | 5 | 27 | 6 | 13.60 | 1.89 | 619.58% |
| 2023-08-22 | 4 | 10 | 6 | 7.75 | 1.83 | 323.5% |
LVTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
LVTX's average broker recommendation rating improved by 0 over the prior 27 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LVTX as an investment opportunity.
- LVTX has a higher upside potential (average analyst target price relative to current price) than 2298.8% of all US stocks.
- LVTX has a higher number of analysts covering the stock than 317.79% of all US stocks.
- In the context of all US stocks, LAVA THERAPEUTICS NV's variance in analysts' estimates is lower than -1355.72% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, LAVA THERAPEUTICS NV's average analyst price target is higher than 701.52% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to LAVA THERAPEUTICS NV are DSGN, HOWL, and JANX.
View All Top Stocks by Price Target
What is the outlook for LVTX? Use POWR Ratings for clearer insight into price direction.